Audrey Ncube

Audrey Ncube

Auto-generated profile, based on publicly available information

Audrey Ncube

Institute for Stem Cell Research and Regenerative Medicine, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Stem Cell Research
Verified
Journal Article
Open access
MBMartina Bohndorf
Martina Bohndorf
ANAudrey Ncube
Audrey Ncube
LSLucas-Sebastian Spitzhorn
Lucas-Sebastian Spitzhorn
JEJürgen Enczmann
Jürgen Enczmann
WWWasco Wruck
Wasco Wruck
James AdjayeJames Adjaye
James Adjaye
SIX2-positive renal cells isolated from urine from a 51year old male of African origin bearing the CYP2D6 *4/*17 variant were reprogrammed by nucleofection of a combination of two episomal-based plasmids omitting pathway (TGFβ, MEK and GSK3β) inhibition. The induced pluripotent stem cells (iPSCs) were characterized by immunocytochemistry, embryoid body formation, DNA-fingerprinting and karyotype analysis. Comparative transcriptome analyses with human embryonic stem cell lines H1 and H9 revealed a Pearson correlation of 0.9243 and 0.9619 respectively.

4 January 2020
Verified
Book Chapter
Closed access
PDF file
Nina GraffmannNina Graffmann
Nina Graffmann
LSLucas-Sebastian Spitzhorn
Lucas-Sebastian Spitzhorn
ANAudrey Ncube
Audrey Ncube
WWWasco Wruck
Wasco Wruck
James AdjayeJames Adjaye
James Adjaye

3 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
Claus KordesClaus Kordes
Claus Kordes
LSLucas-Sebastian Spitzhorn
Lucas-Sebastian Spitzhorn
MBMartina Bohndorf
Martina Bohndorf
ANAudrey Ncube
Audrey Ncube
CTChantelle Thimm
Chantelle Thimm
James AdjayeJames Adjaye
James Adjaye
Cells with the characteristics of renal progenitor cells are shed in urine. The aim of this study was to investigate whether these SIX2-positive urine-derived renal progenitor cells (UdRPC) have therapeutic potential in treating or managing acute to chronic kidney injuries. Human UdRPC were obtained from a woman aged 35 years, expanded, and characterized in vitro and finally transplanted unilaterally under the renal capsule of mouse kidneys that had undergone ischemia reperfusion injury (IRI). Analyses of blood serum from the mice revealed that the transplanted human UdRPC transiently influenced the secretome of the animals by triggering the release of inflammatory and angiogenic factors. Of obvious therapeutic relevance, however, was the finding that the transplanted cells suppressed renal fibrosis resulting from IRI. The expression of genes linked to inflammation and chronic kidney disease was also reduced in mouse kidneys in the presence of UdRPC. Ultimately, the human UdRPC were able to alleviate the severity of the injury through the amelioration of fibrosis but were unable to restore complete kidney function within 21 days. Nevertheless, the findings of this study demonstrate a significant influence of transplanted UdRPC on kidney fibrosis after acute to chronic injury presumably via an altered secretome.

10 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ANAudrey Ncube
Audrey Ncube
Nina GraffmannNina Graffmann
Nina Graffmann
JGJan Greulich
Jan Greulich
BSBo Scherer
Bo Scherer
WWWasco Wruck
Wasco Wruck
James AdjayeJames Adjaye
James Adjaye
Currently, the only treatment of end-stage liver diseases is liver transplantation. The worldwide shortage of donor organs and the high number of patients suffering from end-stage liver diseases, require alternative treatment approaches. Therefore, the generation of hepatocyte-like cells (HLCs) derived from induced pluripotent stem cells (iPSCs) is a promising treatment option. HLCs are suitable for patient-specific drug screening, disease modeling and regenerative medicine. So far, they are immature and resemble the fetal state. In this study, we employed the combined thyroid hormones triiodo-L-thyronine (T3) and L-thyroxine (T4) to drive HLCs towards maturation. HLCs expressed the maturation markers ALBUMIN (ALB), ALPHA-1 ANTITRYPSIN (A1AT), CYTOCHROME P450 3A4 (CYP3A4) and TRANSTHYRETIN (TTR). Remarkably, stimulation with T3 and T4 slightly reduced the expression of the fetal marker CYTOCHROME P450 3A7 (CYP3A7) and had an even more pronounced effect on ALPHA-FETOPROTEIN (AFP) levels. Comparative transcriptome and associated pathways in unstimulated and T3 and T4 stimulated HLCs revealed regulated expression of numerous genes within for example the peroxisome proliferator-activated receptor (PPAR), transforming growth factor beta (TGF-β), mitogen-activated protein kinase/extracellular-signal-regulated kinase (MAPK/ERK) signaling pathways and thyroid hormone synthesis. We propose the inclusion of combined T3 andT4 in HLC differentiation protocols to enhance maturation and therefore provide additional improvement in their applications in drug screening and disease modeling.